Traumatic brain injury linked to dementia onset in seniors
Researchers report that traumatic brain injuries (TBI) in older adults are associated with new cases of dementia, use of home care services, and admission to long-term care. The… read more.
Researchers report that traumatic brain injuries (TBI) in older adults are associated with new cases of dementia, use of home care services, and admission to long-term care. The… read more.
Neurocrine Biosciences, Inc. presented new data from the open-label KINECT-HD2 study demonstrating an established long-term safety profile, tolerability and sustained improvements in chorea severity through three years of… read more.
Newron Pharmaceuticals announced that it will present three posters at the upcoming 38th Congress of the European College of Neuropsychopharmacology taking place in Amsterdam, the Netherlands, from October 11… read more.
Research supported by the National Institutes of Health (NIH) shows that repeated head impacts from contact sports can cause early and lasting changes in the brains of young-… read more.
Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer’s disease. The diagnostic is intended for use in primary care. Using a tablet… read more.
Eisai Co., Ltd. announced that the in-house discovered and developed orexin receptor antagonist Dayvigo (brand name in China: “达卫可®“ generic name: lemborexant) has launched in China for the… read more.
NICE (UK): Idebenone is recommended, within its marketing authorisation, as an option for treating visual impairment in Leber’s hereditary optic neuropathy (LHON) in people 12 years and over…. read more.
Alexion, AstraZeneca Rare Disease, will present four abstracts, including one oral presentation, from its leading rare neurology portfolio at the European Committee for Treatment and Research in Multiple… read more.
-BioXcel Therapeutics, Inc announced that the SERENITY At-Home Pivotal Phase III trial evaluating the safety of BXCL 501, the Company’s proprietary, sublingual film formulation of dexmedetomidine, as an… read more.
Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds… read more.
Over an 18-month period, patients suffering with insomnia who were treated with cannabis- based medical products reported improvement in sleep. The findings were published on Aug. 27, 2025… read more.
Biogen Inc and Stoke Therapeutics Inc, a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, announced presentations of new clinical data… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.